(Q35563874)

8 August 2017

1 reference

title

Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts (English)

1 reference

8 August 2017

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

23 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

23 March 2024

Paul J Thornalley

1

0 references

language of work or name

English

0 references

publication date

1 November 2003

1 reference

full work available at URL

8 August 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

https://api.elsevier.com/content/article/PII:S0003986103004399?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

https://api.elsevier.com/content/article/PII:S0003986103004399?httpAccept=text/plain

23 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Archives of Biochemistry and Biophysics

23 March 2024

published in

1 reference

8 August 2017

volume

419

1 reference

8 August 2017

issue

1

1 reference

8 August 2017

page(s)

31-40

1 reference

Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking

8 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Assay of advanced glycation endproducts (AGEs): surveying AGEs by chromatographic assay with derivatization by 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and application to N∊-carboxymethyl-lysine- and N∊-(1-carboxyethyl)lysine-modified albu

23 March 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Chromatographic assay of glycation adducts in human serum albumin glycated in vitro by derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and intrinsic fluorescence

23 March 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Kinetics and mechanism of the reaction of aminoguanidine with the alpha-oxoaldehydes glyoxal, methylglyoxal, and 3-deoxyglucosone under physiological conditions.

23 March 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Cellular and Molecular Biology

23 March 2024

5

44

1139

Degenhardt

1998

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

The reaction of some dicarbonyl sugars with aminoguanidine

23 March 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Rapid induction of messenger RNA for nitric oxide synthase II in rat neutrophils in vivo by endotoxin and its suppression by prednisolone.

23 March 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Formation of reactive intermediates from Amadori compounds under physiological conditions

23 March 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

3-Deoxy-L-glycero-pentos-2-ulose (3-deoxy-L-xylosone) and L-threo-pentos-2-ulose (L-xylosone) as intermediates in the degradation of L-ascorbic acid

23 March 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Discordant effects of guanidines on renal structure and function and on regional vascular dysfunction and collagen changes in diabetic rats

23 March 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

The pharmacokinetics of aminoguanidine in end-stage renal disease patients on hemodialysis

23 March 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction

23 March 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Aminoguanidine treatment reduces the increase in collagen stability of rats with experimental diabetes mellitus

23 March 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Nitric oxide synthases: structure, function and inhibition

23 March 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

The reaction of methylglyoxal with aminoguanidine under physiological conditions and prevention of methylglyoxal binding to plasma proteins.

23 March 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Toxicity of mildly modified low-density lipoproteins to cultured retinal capillary endothelial cells and pericytes

23 March 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity: implications for advanced glycation and diabetic complications

23 March 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

The glyoxalase system in health and disease

23 March 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Hyperglycemic pseudohypoxia and diabetic complications.

23 March 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Effects of aminoguanidine on insulin release from pancreatic islets

23 March 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

23 March 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

The effect of aminoguanidine and tolrestat on glucose toxicity in bovine retinal capillary pericytes

23 March 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

The reaction of D-glucose with aminoguanidine

23 March 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Aminoguanidine inhibits protein browning without extensive Amadori carbonyl blocking

23 March 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Glycation cross-links inhibit matrix metalloproteinase-2 activation in vascular smooth muscle cells cultured on collagen lattice

23 March 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency

23 March 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Aminoguanidine: a drug proposed for prophylaxis in diabetes inhibits catalase and generates hydrogen peroxide in vitro

23 March 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Aminoguanidine inhibits reactive oxygen species formation, lipid peroxidation, and oxidant-induced apoptosis

23 March 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Effect of aminoguanidine on lipid peroxidation in streptozotocin-induced diabetic rats

23 March 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Efficient scavenging of fatty acid oxidation products by aminoguanidine

23 March 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Chelating activity of advanced glycation end-product inhibitors

23 March 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Comparison of antioxidant activities of aminoguanidine, methylguanidine and guanidine by luminol-enhanced chemiluminescence

23 March 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Accumulation of alpha-oxoaldehydes during oxidative stress: a role in cytotoxicity

23 March 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

DNA modification in vivo by derivatives of glucose: enhancement by glutathione depletion

23 March 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Oxidative DNA damage induced by high glucose and its suppression in human umbilical vein endothelial cells

23 March 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Biochemistry and molecular cell biology of diabetic complications

23 March 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

American Journal of Physiology

23 March 2024

44

280

E685

Wautier

2001

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Mechanisms underlying endothelial dysfunction in diabetes mellitus

23 March 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Aminoguanidine is an isoform-selective, mechanism-based inactivator of nitric oxide synthase

23 March 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Diabetic nephropathy: prevention and treatment

23 March 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Advanced glycation end products and the progressive course of renal disease.

23 March 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Retardation by Aminoguanidine of Development of Albuminuria, Mesangial Expansion, and Tissue Fluorescence in Streptozocin-Induced Diabetic Rat

23 March 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Renoprotective effects of a novel inhibitor of advanced glycation

23 March 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Aminoguanidine inhibits albuminuria, but not the formation of advanced glycation end-products in skin collagen of diabetic rats

23 March 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Relative contributions of advanced glycation and nitric oxide synthase inhibition to aminoguanidine-mediated renoprotection in diabetic rats

23 March 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy

23 March 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Effects of inhibition of glycation and oxidative stress on the development of diabetic nephropathy in rats

23 March 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Effects of heparin and aminoguanidine on glomerular basement membrane thickening in diabetic rats

23 March 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Prevention of albuminuria by aminoguanidine or ramipril in streptozotocin-induced diabetic rats is associated with the normalization of glomerular protein kinase C

23 March 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

AGEs induce oxidative stress and activate protein kinase C-beta(II) in neonatal mesangial cells

23 March 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Aminoguanidine ameliorates albuminuria in diabetic hypertensive rats

23 March 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

ALT-946 and aminoguanidine, inhibitors of advanced glycation, improve severe nephropathy in the diabetic transgenic (mREN-2)27 rat.

23 March 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Ramipril and aminoguanidine restore renal lysosomal processing in streptozotocin diabetic rats

23 March 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Effects of aminoguanidine on serum advanced glycation endproducts, urinary albilmin excretion, mesangial expansion, and glomerular basement membrane thickening in Otsuka Long-Evans Tokushima fatty rats

23 March 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

The effects of aminoguanidine on renal changes in a baboon model of Type 1 diabetes

23 March 2024

65

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Diabetic retinopathyA clinical update

23 March 2024

66

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Early cellular and molecular changes induced by diabetes in the retina

23 March 2024

67

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy

23 March 2024

68

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Aminoguanidine does not inhibit the initial phase of experimental diabetic retinopathy in rats

23 March 2024

69

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Aminoguanidine inhibits the development of accelerated diabetic retinopathy in the spontaneous hypertensive rat

23 March 2024

70

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Secondary intervention with aminoguanidine retards the progression of diabetic retinopathy in the rat model

23 March 2024

71

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Effect of aminoguanidine on optic nerve involvement in experimental diabetic rats

23 March 2024

72

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Depletion of nitric oxide synthase-containing neurons in the diabetic retina: reversal by aminoguanidine

23 March 2024

73

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin

23 March 2024

74

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Glycation in diabetic neuropathy: characteristics, consequences, causes, and therapeutic options

23 March 2024

76

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals

23 March 2024

77

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Effect of aminoguanidine on the frequency of neuroaxonal dystrophy in the superior mesenteric sympathetic autonomic ganglia of rats with streptozocin-induced diabetes

23 March 2024

78

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Functional and structural abnormalities in the nerves of type I diabetic baboons: aminoguanidine treatment does not improve nerve function

23 March 2024

79

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Inhibition of cataracts in moderately diabetic rats by aminoguanidine

23 March 2024

80

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Advanced glycation end-products are responsible for the impairment of corpus cavernosal smooth muscle relaxation seen in diabetes

23 March 2024

81

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Potential benefit of inhibitors of advanced glycation end products in the progression of type II diabetes: a study with aminoguanidine in C57/BLKsJ diabetic mice

23 March 2024

82

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

alpha-Dicarbonyls increase in the postprandial period and reflect the degree of hyperglycemia

23 March 2024

83

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Aminoguanidine and the prevention of leukocyte dysfunction in diabetes mellitus: a direct vital microscopic study

23 March 2024

84

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Glucose and palmitic acid induce degeneration of myofibrils and modulate apoptosis in rat adult cardiomyocytes

23 March 2024

85

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy

23 March 2024

86

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Prevention of cardiovascular and renal pathology of aging by the advanced glycation inhibitor aminoguanidine.

23 March 2024

87

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Chronic aminoguanidine attenuates renal dysfunction and injury in aging rats

23 March 2024

88

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Effect of chronic aminoguanidine treatment on age-related glycation, glycoxidation, and collagen cross-linking in the Fischer 344 rat.

23 March 2024

89

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Age-dependent accumulation of advanced glycation end-products in adult Drosophila melanogaster.

23 March 2024

90

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Protein glycosylation and advanced glycosylated endproducts (AGEs) accumulation: an avian solution?

23 March 2024

91

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Effect of dietary aminoguanidine on tissue pentosidine and reproductive performance in broiler breeder hens

23 March 2024

92

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Aminoguanidine supplementation delays the onset of senescence in vitro in dermal fibroblast-like cells from senescence-accelerated mice

23 March 2024

93

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

The nitric oxide hypothesis of aging.

23 March 2024

94

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Design and baseline characteristics for the aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II).

23 March 2024

95

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

In vivo formation of a Schiff base of aminoguanidine with pyridoxal phosphate

23 March 2024

96

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

Aminoguanidine pyridoxal adduct is superior to aminoguanidine for preventing diabetic nephropathy in mice

23 March 2024

97

1 reference

https://api.crossref.org/works/10.1016/J.ABB.2003.08.013

23 March 2024

Identifiers

1 reference

8 August 2017

1 reference